Home / KALA : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does KALA make money? Does KALA have pricing power? What's the Earnings Whisper? Will KALA profit more as the business scales? What is KALA's management track record? Is KALA's current price justified?

KALA BIO, Inc.

$0.57 -$30.49 (-98.16%)

NASDAQ · 11 Sep 2026 20:00 UTC

Previous Close

$0.56

Day Range

$0.57$0.6

Year Range

$0.49$1030

Market Cap

11.07M

AVG Volume

266.62K

Trailing/Forward PE

-0.01/-

PEG ratio

Dividend Yield

Next Earnings Date

2026-11-10

Primary Exchange

NASDAQ

Revenue (USD)

KALA Revenue (USD) by year
Period	Revenue (USD)
2025	0
2024	0
2023	0
2022	3.89M
2021	11.24M
2020	6.36M
2019	6.07M
2018	0
2017	0
2016	0

Net Income (USD)

KALA Net Income (USD) by year
Period	Net Income (USD)
2025	-26.98M
2024	-38.51M
2023	-42.2M
2022	-44.82M
2021	-142.6M
2020	-104.33M
2019	-94.35M
2018	-66.74M
2017	-42.21M
2016	-33.17M

Operating Income (USD)

KALA Operating Income (USD) by year
Period	Operating Income (USD)
2025	-39.16M
2024	-40.43M
2023	-39.15M
2022	-81.36M
2021	-109.43M
2020	-96.23M
2019	-88.22M
2018	-64.72M
2017	-39.88M
2016	-32.67M

EBITDA (USD)

KALA EBITDA (USD) by year
Period	EBITDA (USD)
2025	-23.39M
2024	-32.47M
2023	-35.99M
2022	-36.6M
2021	-132.07M
2020	-93.39M
2019	-86.48M
2018	-63.77M
2017	-40.98M
2016	-32.31M

Cash Flows (USD)

KALA Cash Flows (USD) by year
Period	Cash Flows (USD)
2025	-31.99M
2024	-29.45M
2023	-28.54M
2022	-79.22M
2021	-109.12M
2020	-92.64M
2019	-94.06M
2018	-55.7M
2017	-34.58M
2016	-27.5M

EPS (USD)

KALA EPS (USD) by year
Period	EPS (USD)
2025	-209.49
2024	-11.03
2023	-17.94
2022	-29.48
2021	-110.9
2020	-100.12
2019	-138
2018	-122.43
2017	-103.06
2016	-95.95

Expenses (USD)

KALA Expenses (USD) by year
Period	Expenses (USD)
2025	42.37M
2024	40.24M
2023	39.37M
2022	83M
2021	117.21M
2020	99.52M
2019	92.56M
2018	65.34M
2017	39.89M
2016	32.74M

Cash & Debt (USD)

KALA Cash & Debt (USD) by year
Period	Cash & Debt (USD)
2025	7.56M
2024	51.18M
2023	50.9M
2022	70.5M
2021	92.14M
2020	153.54M
2019	85.45M
2018	170.9M
2017	114.56M
2016	45.47M

Debt ratios

KALA Debt ratios by year
Period	Debt ratios
2025	0.06
2024	0.08
2023	0.05
2022	0.08
2021	0.03
2020	0.18
2019	-0.07

Margins

KALA Margins by year
Period	Margins
2022	34.22%
2021	61.34%
2020	21.24%
2019	49.47%

Return on Capital

KALA Return on Capital by year
Period	Return on Capital
2025	-385.65%
2024	-312.29%
2023	-562.35%
2022	-236.23%
2021	-848.64%
2020	-104.33%
2019	-317.75%
2018	-63.57%
2017	-47.07%
2016	37.79%

Shares Outstanding

KALA Shares Outstanding by year
Period	Shares Outstanding
2025	0
2024	4.69M
2023	2.71M
2022	1.52M
2021	1.3M
2020	1.14M
2019	697.98K
2018	664.68K
2017	490.31K
2016	345.67K

Book Value Per Share (USD)

KALA Book Value Per Share (USD) by year
Period	Book Value Per Share (USD)
2024	2.63
2023	2.77
2022	12.48
2021	12.92
2020	87.83
2019	42.54
2018	157.95
2017	182.9
2016	-253.89

Total Assets (USD)

KALA Total Assets (USD) by year
Period	Total Assets (USD)
2025	9.49M
2024	55.48M
2023	55.95M
2022	86.82M
2021	139.43M
2020	221.61M
2019	154.32M
2018	220.97M
2017	116.13M
2016	46.33M

Employee Count

KALA Employee Count by year
Period	Employee Count
2025	6
2024	38
2023	43
2022	34
2021	192
2020	188
2019	136
2018	130
2017	37

Free Cash Flow Yield

KALA Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	-46793.05%
Sep 26	-52797.84%
Aug 26	-38812.26%
Aug 26	-32659.85%
Aug 26	-11607.42%
Aug 26	-14676.14%
Jul 26	-14518.87%
Jul 26	-17304.97%
Jul 26	-14146.45%
Jul 26	-9300.69%
Jul 26	-6532.63%
Jun 26	-4355.08%
Jun 26	-3040.11%
Jun 26	-4172.93%
Jun 26	-5327.58%
May 26	-4921.44%
May 26	-4516.38%
May 26	-3745.67%
Apr 26	-2244.38%
Apr 26	-2676.9%
Mar 26	-2594.58%
Mar 26	-1924.02%
Mar 26	-1627.17%
Mar 26	-1638.88%
Feb 26	-1198.97%
Feb 26	-1198.97%
Feb 26	-1120.53%
Feb 26	-1035.47%
Jan 26	-859.64%
Jan 26	-753.07%
Jan 26	-674.98%
Jan 26	-721.36%
Jan 26	-733.43%
Dec 25	-700.94%
Dec 25	-732.25%
Dec 25	-674.78%
Dec 25	-506.23%
Nov 25	-471.55%
Nov 25	-734.85%
Nov 25	-563.12%
Nov 25	-557.12%
Oct 25	-509.84%
Oct 25	-499.72%
Oct 25	-303.57%
Oct 25	-278.09%
Oct 25	-258.23%
Sep 25	-20.88%
Sep 25	-20.26%
Sep 25	-21.36%
Sep 25	-27.33%
Aug 25	-35.44%
Aug 25	-43.18%
Aug 25	-47.8%
Aug 25	-53.89%
Aug 25	-57.61%
Jul 25	-53.41%
Jul 25	-75.27%
Jul 25	-73.86%
Jul 25	-84.72%
Jun 25	-93.52%
Jun 25	-106.95%
Jun 25	-100.48%
Jun 25	-104.36%
May 25	-116.15%
May 25	-106.95%
May 25	-117.73%
May 25	-3.67%
May 25	-3.35%
Apr 25	-3.95%
Apr 25	-3.63%
Apr 25	-3.72%
Apr 25	-2.96%
Mar 25	-2.32%
Mar 25	-2.03%
Mar 25	-2.14%
Mar 25	-1.99%
Feb 25	-2.03%
Feb 25	-2.11%
Feb 25	-1.68%
Feb 25	-1.27%
Jan 25	-1.53%
Jan 25	-1.73%
Jan 25	-1.94%
Jan 25	-2.06%
Jan 25	-1.77%
Dec 24	-2.01%
Dec 24	-2.37%
Dec 24	-2.27%
Dec 24	-2.07%
Nov 24	-2.05%
Nov 24	-2.07%
Nov 24	-2.1%
Nov 24	-2.69%
Nov 24	-2.93%
Oct 24	-3.01%
Oct 24	-3.94%
Oct 24	-3.89%
Oct 24	-3.79%
Sep 24	-3.83%
Sep 24	-3.54%

Price to Sales

KALA Price to Sales by year
Period	Price to Sales
Nov 23	1583.33
Nov 23	1989.83
Oct 23	1938.66
Oct 23	2092.16
Oct 23	2322.36
Oct 23	2518.5
Sep 23	2529.92
Sep 23	2940.51
Sep 23	3021.7
Sep 23	3146.77
Sep 23	3755.09
Aug 23	3865.95
Aug 23	3880.16
Aug 23	3826.15
Aug 23	4013.77
Jul 23	608.44
Jul 23	604.74
Jul 23	592.43
Jul 23	613.37
Jun 23	599
Jun 23	603.92
Jun 23	593.25
Jun 23	594.48
Jun 23	678.23
May 23	617.88
May 23	681.11
May 23	668.38
May 23	299.28
Apr 23	308.07
Apr 23	307.68
Apr 23	324.87
Apr 23	269.58
Mar 23	294
Mar 23	304.16
Mar 23	270.76
Mar 23	368.24
Mar 23	327.21
Feb 23	149.95
Feb 23	165.99
Feb 23	192.07
Feb 23	229.23
Jan 23	256.22
Jan 23	237.97
Jan 23	255.83
Jan 23	383.23
Dec 22	497.45
Dec 22	50.59
Dec 22	55.03
Dec 22	65.2
Dec 22	65.46
Nov 22	74.85
Nov 22	80.45
Nov 22	91.14
Nov 22	46.11
Oct 22	53.71
Oct 22	70.21
Oct 22	110.14
Oct 22	118.48
Sep 22	97.15
Sep 22	110.93
Sep 22	136.03
Sep 22	149.85
Sep 22	147.49
Aug 22	128.48
Aug 22	136.03
Aug 22	147.49
Aug 22	133.75
Jul 22	130.01
Jul 22	131.82
Jul 22	133.91
Jul 22	133.63
Jul 22	117.32
Jun 22	142.38
Jun 22	154.71
Jun 22	142.58
Jun 22	149.71
May 22	138.24
May 22	254.7
May 22	197.81
May 22	226.64
Apr 22	187.95
Apr 22	216.74
Apr 22	246.72
Apr 22	298.05
Apr 22	379.08
Mar 22	514.94
Mar 22	436.58
Mar 22	472.96
Mar 22	174.02
Feb 22	190.08
Feb 22	200.16
Feb 22	199.51
Feb 22	220.53
Jan 22	220.78
Jan 22	226.83
Jan 22	291.05
Jan 22	302.25
Dec 21	338.63
Dec 21	380.61
Dec 21	391.8

Price to Book

KALA Price to Book by year
Period	Price to Book
Sep 26	0
Sep 26	0
Aug 26	0.01
Aug 26	0.01
Aug 26	0.02
Aug 26	0.02
Jul 26	0.02
Jul 26	0.01
Jul 26	0.02
Jul 26	0.03
Jul 26	0.04
Jun 26	0.06
Jun 26	0.08
Jun 26	0.06
Jun 26	0.05
May 26	0.05
May 26	0.05
May 26	0.06
Aug 25	8.34
Jul 25	8.99
Jul 25	6.38
Jul 25	6.5
Jul 25	5.67
Jun 25	5.14
Jun 25	4.49
Jun 25	4.78
Jun 25	4.6
May 25	4.14
May 25	4.49
May 25	4.08
May 25	65.1
May 25	71.38
Apr 25	60.53
Apr 25	65.76
Apr 25	64.15
Apr 25	80.71
Mar 25	204.09
Mar 25	233.44
Mar 25	220.96
Mar 25	237.82
Feb 25	233.77
Feb 25	223.99
Feb 25	282.69
Feb 25	371.74
Jan 25	310.35
Jan 25	273.58
Jan 25	244.57
Jan 25	229.73
Jan 25	267.51
Dec 24	235.46
Dec 24	199.7
Dec 24	208.47
Dec 24	229.05
Nov 24	231.33
Nov 24	229.22
Nov 24	226.02
Nov 24	84.28
Nov 24	77.21
Oct 24	75.11
Oct 24	57.44
Oct 24	58.2
Oct 24	59.65
Sep 24	59.09
Sep 24	63.95
Sep 24	65.28
Sep 24	66.27
Aug 24	64.62
Aug 24	66.38
Aug 24	67.49
Aug 24	64.62
Aug 24	124.59
Jul 24	145.81
Jul 24	142.75
Jul 24	157.96
Jul 24	145.71
Jun 24	149.72
Jun 24	114.03
Jun 24	125.86
Jun 24	138.74
May 24	141.91
May 24	137.51
May 24	138.32
May 24	124.71
May 24	126.65
Apr 24	113.86
Apr 24	119.1
Apr 24	130.13
Apr 24	137.36
Mar 24	90.55
Mar 24	90.78
Mar 24	85.55
Mar 24	85.21
Mar 24	83.28
Feb 24	80.21
Feb 24	80.55
Feb 24	83.73
Feb 24	79.08
Jan 24	80.89
Jan 24	84.3
Jan 24	91.46

No video analysis for this stock yet. Request one from our team.

News: KALA

globenewswire.com · 3 Sep 2026

Kala Bio and Virotek Finalize Definitive Agreement Establishing Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program

Agreement Grants Kala Exclusive U.S. Rights to Market and Distribute Virotek's Ophthalmology Genomic Testing Program Agreement Grants Kala Exclusive U.S. Rights to Market and Distribute Virotek's Ophthalmology Genomic Testing Program

globenewswire.com · 1 Sep 2026

Kala Bio and Virotek Announce Letter of Intent to Establish an Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program

ARLINGTON, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Kala Bio, Inc. (Nasdaq: KALA) ("Kala") and Virotek Inc. ("Virotek"), a CLIA-registered precision health and clinical genomics company, today announced that they have entered into a letter of intent (the "LOI") outlining the principal terms under which the companies intend to negotiate a definitive agreement appointing Kala as the exclusive distributor and reseller in the United States of Virotek's genetic testing and screening program for ophthalmological indications.

defenseworld.net · 30 Jul 2026

KALA BIO (KALA) Expected to Post Earnings on Thursday

KALA BIO (NASDAQ: KALA - Get Free Report) is anticipated to release its Q2 2026 results before the market opens on Thursday, August 6th. Analysts expect KALA BIO to post earnings of ($6.00) per share for the quarter. Parties can find conference call details on the company's upcoming Q2 2026 earning report for the latest details